Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-13 FOEHR MATTHEW W President and COO Grant or award · Employee Stock Option (right to buy) +33,210 33,210
2020-02-13 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award +3,835 52,904
2020-02-13 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award · Employee Stock Option (right to buy) +17,220 17,220
2020-02-13 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award +6,848 26,864
2020-02-13 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award · Employee Stock Option (right to buy) +30,750 30,750
2019-12-20 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award +2,674 19,825
2019-12-20 Korenberg Matthew E EVP,Finance & Strategy and CFO Shares withheld for taxes −1,135 $105.87 $120K 18,690
2019-12-20 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award +2,305 20,995
2019-12-20 Korenberg Matthew E EVP,Finance & Strategy and CFO Shares withheld for taxes −979 $105.87 $104K 20,016
2019-12-20 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award +1,693 48,865
2019-12-20 Berkman Charles S SVP, Gen. Counsel & Secretary Shares withheld for taxes −585 $105.87 $62K 48,280
2019-12-20 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award +1,335 49,615
2019-12-20 Berkman Charles S SVP, Gen. Counsel & Secretary Shares withheld for taxes −546 $105.87 $58K 49,069
2019-12-20 FOEHR MATTHEW W President and COO Grant or award +4,458 149,078
2019-12-20 FOEHR MATTHEW W President and COO Shares withheld for taxes −2,210 $105.87 $234K 146,868
2019-12-20 FOEHR MATTHEW W President and COO Grant or award +2,913 149,781
2019-12-20 FOEHR MATTHEW W President and COO Shares withheld for taxes −1,444 $105.87 $153K 148,337
2019-12-20 HIGGINS JOHN L Chief Executive Officer Grant or award +7,668 154,417
2019-12-20 HIGGINS JOHN L Chief Executive Officer Shares withheld for taxes −3,801 $105.87 $402K 150,616
2019-12-20 HIGGINS JOHN L Chief Executive Officer Grant or award +5,946 156,562

Page 41 of 43 · 858 trades